ERBB2 and breast cancer: Further, EC50 values of 1.1 and 3.3 nM were observed against SKBr3 and HCC1954 breast cancer cells, respectively, and a complete tumor regression was shown using HER2+ patient-derived colorectal/gastric cancer xenografts (114).